JoVE Logo
Faculty Resource Center

Sign In

Neurogenesis Using P19 Embryonal Carcinoma Cells

DOI :

10.3791/58225-v

April 27th, 2019

April 27th, 2019

10,205 Views

1Department of Experimental Embryology, Institute of Genetics and Animal Breeding, Polish Academy of Sciences, 2Department of Regenerative Medicine, Maria Skłodowska-Curie Institute - Oncology Center, 3Department of Genomics and Biodiversities, Institute of Genetics and Animal Breeding, Polish Academy of Sciences

The P19 mouse embryonic carcinoma cell line (P19 cell line) is widely used for studying the molecular mechanism of neurogenesis with great simplification compared to in vivo analysis. Here, we present a protocol for retinoic acid-induced neurogenesis in the P19 cell line.

Tags

Neurogenesis

-- Views

Related Videos

article

Organotypic Slice Cultures for Studies of Postnatal Neurogenesis

article

Tracking Cells in GFP-transgenic Zebrafish Using the Photoconvertible PSmOrange System

article

The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System

article

Acute and Chronic Models of Hyperglycemia in Zebrafish: A Method to Assess the Impact of Hyperglycemia on Neurogenesis and the Biodistribution of Radiolabeled Molecules

article

Horizontal Whole Mount: A Novel Processing and Imaging Protocol for Thick, Three-dimensional Tissue Cross-sections of Skin

article

Single-cell Photoconversion in Living Intact Zebrafish

article

Identification of Skeletal Muscle Satellite Cells by Immunofluorescence with Pax7 and Laminin Antibodies

article

Computational Analysis of the Caenorhabditis elegans Germline to Study the Distribution of Nuclei, Proteins, and the Cytoskeleton

article

In Vitro Generation of Somite Derivatives from Human Induced Pluripotent Stem Cells

article

Assessment of Oxidative Damage in the Primary Mouse Ocular Surface Cells/Stem Cells in Response to Ultraviolet-C (UV-C) Damage

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved